Relationships between oestradiol-17 beta, testosterone, dihydrotestosterone and 5 alpha-androstane-3 alpha, 27 beta-diol in human benign hypertrophy and carcinoma of the prostate
- PMID: 6162906
- DOI: 10.1677/joe.0.0880255
Relationships between oestradiol-17 beta, testosterone, dihydrotestosterone and 5 alpha-androstane-3 alpha, 27 beta-diol in human benign hypertrophy and carcinoma of the prostate
Abstract
The relationship between the concentrations of oestradiol, testosterone, dihydrotestosterone (DHT) and 5 alpha-androstane-3 alpha, 17 beta-diol in circulating blood and prostatic tissues was studied in patients with benign prostatic hypertrophy (BPH) and carcinoma of the prostate. All steroids were measured by radioimmunoassay. In patients with BPH the tissue concentrations of oestradiol, testosterone, DHT and 5 alpha-androstane-3 alpha, 17 beta-diol expressed per kg wet weight were 228.6 +/- 7.4 (S.E.M.) pmol, 1.29 +/- 0.06 nmol, 25.61 +/- 1.15 nmol and 1.43 +/- 0.10 nmol respectively. The corresponding values for carcinomatous tissues were 380.1 +/- 19.4 pmol, 7.20 +/- 1.10 nmol, 12.32 +/- 1.56 nmol and 1.99 +/- 0.32 nmol. Significant differences (t-test) were found between the mean concentrations of oestradiol (P less than 0.001), testosterone (P less than 0.001), DHT (P less than 0.001) and 5 alpha androstane-3 alpha, 17 beta-diol (P less than 0.05) in prostatic tissues of these two groups of patients. Significant negative correlations were observed between the tissue concentrations of oestradiol and DHT (r = -0.49, P less than 0.05) and between oestradiol and 5 alpha-androstane-3 alpha,17 beta-diol (r = -0.44, P less than 0.05) in BPH but not in malignant tissues. The plasma concentrations of oestradiol, testosterone, DHT and 5 alpha-androstane-3 alpha, 17 beta-diol in patients with BPH were 147.4 +/- 6.9 pmol/l, 18.4 +/- 1.2 nmol/l, 2.6 +/- 0.2 nmol/l and 0.84 +/- 0.04 nmol/ respectively. The corresponding values for patients with carcinoma of the prostate were 145.5 +/- 17.0 pmol/l, 17.3 +/- 2.4 nmol/l, 2.0 +/- 0.3 nmol/l and 0.56 +/- 0.06 nmol/l respectively. The mean plasma 5 alpha-androstane-3 alpha, 17 beta-diol was found to be significantly higher in patients with BPH (P less than 0.01) than with carcinoma. No significant correlations were found between the tissue concentrations of these steroids and the corresponding plasma values, which suggested that their metabolism and accumulation in prostatic tumours are independent of their plasma concentrations.
Similar articles
-
Concentrations of unconjugated 5 alpha-androstane-3 alpha, 17 beta-diol and 5 alpha-androstane-3 beta, 17 beta-diol and their precursor in human testicular tissue. Comparison with testosterone, 5 alpha-dihydrotestosterone, estradiol-17 beta, and with steroid concentrations in human epididymis.J Steroid Biochem. 1987 Mar;26(3):345-8. doi: 10.1016/0022-4731(87)90099-9. J Steroid Biochem. 1987. PMID: 3586650
-
Androgen of the human prostate.Endocr Res Commun. 1976;3(2):105-17. doi: 10.3109/07435807609052926. Endocr Res Commun. 1976. PMID: 60232
-
Serum levels of follicle stimulating hormone, luteinizing hormone, prolactin, testosterone, 5 alpha-dihydrotestosterone, 5 alpha-androstane-3 alpha, 17 beta-diol, 5 alpha-androstane-3 beta, 17 beta-diol, and 17 beta-estradiol from male beagles with spontaneous or induced benign prostatic hyperplasia.Invest Urol. 1981 Nov;19(3):142-7. Invest Urol. 1981. PMID: 6170603
-
Androgen metabolism in patients with benign prostatic hypertrophy.Vitam Horm. 1975;33:417-38. doi: 10.1016/s0083-6729(08)60968-1. Vitam Horm. 1975. PMID: 59462 Review. No abstract available.
-
Intraprostatic testosterone and dihydrotestosterone. Part I: concentrations and methods of determination in men with benign prostatic hyperplasia and prostate cancer.BJU Int. 2012 Jan;109(2):176-82. doi: 10.1111/j.1464-410X.2011.10651.x. Epub 2011 Oct 12. BJU Int. 2012. PMID: 21992222 Review.
Cited by
-
Urinary unconjugated 5 alpha-androstane-3 alpha, 17 beta-diol in patients with prostatic tumours.Urol Res. 1982;10(2):81-4. doi: 10.1007/BF00262407. Urol Res. 1982. PMID: 6180540
-
Estrogen and androgen signaling in the pathogenesis of BPH.Nat Rev Urol. 2011 Jan;8(1):29-41. doi: 10.1038/nrurol.2010.207. Nat Rev Urol. 2011. PMID: 21228820 Review.
-
High testosterone levels in prostate tissue obtained by needle biopsy correlate with poor-prognosis factors in prostate cancer patients.BMC Cancer. 2014 Sep 26;14:717. doi: 10.1186/1471-2407-14-717. BMC Cancer. 2014. PMID: 25256077 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical